Ads
related to: narcolepsy treatment sunosi- Getting XYWAV
Talk to Your Doctor to See if
XYWAV is Right for You.
- View Oscar's Experience
Watch Oscar Discuss His Routine
& How He Treats With XYWAV.
- Submit Your XYWAV Story
Taking XYWAV? Share Your Story as a
Standup Champion to Inspire Others.
- Support and Resources
Learn About XYWAV Treatment
Support and Resources.
- XYWAV FAQ's
Get Answers to Your Questions
About Your XYWAV Treatment.
- XYWAV Coupon Program
Eligible Patients May Pay As Little
As $5 Per Prescription. Learn More.
- Getting XYWAV
Search results
Axsome's (AXSM) Narcolepsy Drug Study Meets Primary Goal
Zacks via Yahoo Finance· 2 months agoData from a late-stage study shows that a five-week treatment with Axsome's (AXSM) experimental...
Axsome (AXSM) Q1 Loss Widens Y/Y, Revenues Beat Estimates
Zacks via Yahoo Finance· 3 weeks agoAxsome Therapeutics, Inc. AXSM reported an adjusted loss of $1.00 per share for the first quarter of...
Axsome (AXSM) Q3 Loss Narrower Than Expected, Revenues Miss
Zacks via Yahoo Finance· 2 years agoAxsome Therapeutics, Inc. AXSM incurred a loss of $1.03 per share (excluding intangible asset...
Axsome (AXSM) Q4 Earnings Miss, Auvelity Records First Sales
Zacks via Yahoo Finance· 1 year agoAxsome Therapeutics, Inc. AXSM incurred an adjusted loss of $1.28 per share in the fourth quarter of...
Axsome (AXSM) Begins Dosing in Depression Study on Sunosi
Zacks via Yahoo Finance· 2 months agoAxsome (AXSM) doses the first patient in the phase III PARADIGM study evaluating Sunosi...
Axsome (AXSM) up 118.4% in the Past Three Months: Here's Why
Zacks via Yahoo Finance· 2 years agoAxsome Therapeutics’ AXSM shares have surged 118.4% in the past three months against the industry’s...
Axsome (AXSM) Doses First Patient in Late-Stage ADHD Study
Zacks via Yahoo Finance· 11 months agoAxsome AXSM announced that the first patient has been dosed in the late-stage, label expansion study...
Axsome Therapeutics' Sunosi Improves Cognitive Function In Patients With Sleep Disorder
Benzinga via Yahoo Finance· 2 years agoAxsome Therapeutics Inc's (NASDAQ: AXSM) Sunosi met the primary endpoint in the SHARP study and...
Alkermes' (ALKS) ALKS 2680 Betters Wakefulness in Phase Ib Study
Zacks via Yahoo Finance· 2 months agoAlkermes plc ALKS announced positive top-line data from a phase Ib study evaluating its novel,...
Axsome (AXSM) Rides on New Drug Approval & Sunosi Buyout
Zacks via Yahoo Finance· 1 year agoAxsome (AXSM) receives FDA approval for Auvelity to treat major depressive disorder in August. The...
Ads
related to: narcolepsy treatment sunosi
